Genus PLCGNS:LSE

1,462
12.00 / 0.83%
13.77k
20.23%
0.6789
Latest price in GBXToday's changeShares traded1 year changeBeta
As of May 22 2013 15:29 BST.Data delayed by at least 15 minutes.

Summary

As of last trade Genus PLC (GNS:LSE) traded at 1,462, 9.14% below its 52-week high of 1,609, set on Apr 02, 2013.

52-week range
Today
1,129
Jun 18 2012
1,609
Apr 02 2013
Markit short selling activity
Low
Medium
High
Open1,441
Day high1,462
Day low1,441
Bid1,459
Offer1,462
Previous close1,450
Average volume96.22k
Shares outstanding60.64m
Free float60.09m
P/E (TTM)22.91
Market cap879.31m GBP
EPS (TTM)0.6329 GBP
Annual div (TTM)15.10 GBX
Annual div yield (TTM)1.04%
Div ex-dateMar 13 2013
Div pay-dateApr 08 2013
Last IC View
The last IC recommendation on Genus PLC shares was Hold at 1,437 on 25 Feb 2013
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Genus PLC+3.18%+5.03%+13.69%+20.23%+69.21%
FTSE 100 Index+2.58%+9.33%+19.37%+27.08%+11.08%
GB/HEALTH CARE+1.41%+4.33%+20.15%+19.20%--
WRLD/BIOTECHNOLOGY-1.79%+1.29%+28.51%+40.69%+57.30%
As of May 22 2013 15:29 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.